Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon
JAC-Antimicrobial Resistance · 30.04.2026 · 8 (3)
DOI: 10.1093/jacamr/dlag118 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 17.06.2026. Verfasst von Jame Tannous und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Lebanese American University, Byblos, Lebanon. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: internal institutional funding.
Abstract (Originalsprache)
Background
Contemporary multicentre data on carbapenemase distribution among carbapenem-resistant Enterobacterales (CRE) in Lebanon remain limited. This study aimed to characterize the distribution of carbapenemase enzyme families among clinical CRE isolates collected from Lebanese hospitals.
Methods
A multicentre study was conducted across 14 hospitals representing different Lebanese regions between March and October 2025. CRE isolates were centrally processed using standardized phenotypic microbiological methods and interpreted according to the 2025 European Committee on Antimicrobial Susceptibility Testing breakpoints. Carbapenemase identification was performed using NG-Test® CARBA-5. Agreement between phenotypic prediction and rapid immunochromatographic testing was evaluated.
Results
A total of 59 non-duplicate CRE isolates from individual patients were included. New Delhi metallo-β-lactamase (NDM) was the predominant carbapenemase enzyme family (64.4%), followed by OXA-48–like enzymes (23.7%), with co-production observed in 10.2% of isolates. Among carbapenem-resistant Escherichia coli (34 isolates), NDM predominated (73.5%). In contrast, carbapenem-resistant Klebsiella pneumoniae (15 isolates) more frequently harboured OXA-48–like enzymes (53.3%), although NDM-producing isolates were also identified (33.3%). No NDM-producing isolate was susceptible to ceftazidime–avibactam, whereas OXA-48–like producers retained higher susceptibility (71.4%). Phenotypic carbapenemase prediction showed high agreement with NG-Test® CARBA-5 results (κ = 0.89), including 100% sensitivity for metallo-β-lactamase detection.
Conclusions
NDM was the predominant carbapenemase among CRE isolates recovered from participating Lebanese hospitals, while Oxacillinase-48 carbapenemase (OXA-48)–like enzymes remained common. These findings highlight the importance of carbapenemase-specific characterization, as therapeutic options differ according to the underlying resistance mechanism. Rapid carbapenemase detection using NG-Test® CARBA-5, coupled with phenotypic prediction, may support resistance mechanism-guided therapy, antimicrobial stewardship and surveillance efforts.
Autor:innen und Institutionen
- Department of Biological Sciences, Lebanese American University, Byblos, Lebanon.
- Department of Laboratory Medicine, Clemenceau Medical Center, Beirut, Lebanon.
- Department of Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
- Department of Laboratory Medicine, Makassed Hospital, Beirut, Lebanon.
- Department of Laboratory Medicine, Abdallah Al Rasi Governmental Hospital, Halba, Lebanon.
- Department of Internal Medicine, Ain Wazein Medical Village, Chouf, Lebanon.
ORCID-Profile: Sima Tokajian
Förderung
- internal institutional funding
Zitieren
APA
Tannous, J., Saliba, R., Mghames, A., Tokajian, S., Attieh, R., Jisr, T., Barhoun, J., Diab, M. K., Shakra, D. A., Mokhbat, J., Al Souheil, A., Zorkot, W., Jaffal, F., Salman, H., Husni, R., Rahban, H., Khoury, E., Mohsen, Z., Abboud, E., …, & Moghnieh, R. (2026). Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon. JAC-Antimicrobial Resistance, 8(3). https://doi.org/10.1093/jacamr/dlag118
Vancouver
Tannous J, Saliba R, Mghames A, Tokajian S, Attieh R, Jisr T, et al. Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon. JAC-Antimicrobial Resistance. 2026;8(3). doi:10.1093/jacamr/dlag118
BibTeX
@article{Tannous2026,
author = {Tannous, Jame and Saliba, Rindala and Mghames, Abdo and Tokajian, Sima and Attieh, Rana and Jisr, Tamima and Barhoun, Jamil and Diab, Mohamad Khaled and Shakra, Diaa Abou and Mokhbat, Jacques and Al Souheil, Anwar and Zorkot, Wael and Jaffal, Fatima and Salman, Hasan and Husni, Rola and Rahban, Hind and Khoury, Eliane and Mohsen, Zeina and Abboud, Edmond and Youssef, Mona and Karayakoupoglo, Gilbert and Fawaz, Ismail and Houmani, Mohamad and Abdallah, Dania and Moghnieh, Rima},
title = {Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {3},
doi = {10.1093/jacamr/dlag118}
}
EUVIMED